Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 37 entries
Sorted by: Best Match Show Resources per page
[Aneurysmal bone cyst.].

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca

Gajdos M, Sulla I, Výrostko J.
PMID: 20470514
Acta Chir Orthop Traumatol Cech. 1995;62(4):251-3.

The authors present a report on a female patient with an aneurysmatic bone cyst affecting the entire body of the fifth lumbar vertebra. They draw attention to the rare incidence, diagnostic and therapeutic possibilities of aneurysmal bone cysts with...

Cite
Gajdos M, Sulla I, Výrostko J. Aneuryzmatická kostná cysta. [Aneurysmal bone cyst.]. Acta Chir Orthop Traumatol Cech. 1995;62(4):251-3
Gajdos, M., Sulla, I., & Výrostko, J. (1995). Aneuryzmatická kostná cysta. [Aneurysmal bone cyst.]. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, 62(4), 251-3.
Gajdos, M, et al. "Aneuryzmatická kostná cysta." [Aneurysmal bone cyst.]. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca vol. 62,4 (1995): 251-3.
Gajdos M, Sulla I, Výrostko J. Aneuryzmatická kostná cysta. [Aneurysmal bone cyst.]. Acta Chir Orthop Traumatol Cech. 1995;62(4):251-3. Slovak. PMID: 20470514.
Copy Download .nbib Format: NLM
Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report.

Journal of ophthalmology

Wirostko WJ, Nordgren RN, Dubis AM.
PMID: 22292111
J Ophthalmol. 2012;2012:347206. doi: 10.1155/2012/347206. Epub 2012 Jan 12.

Purpose. To describe topographical changes in choroidal thickness as measured by optical coherence tomography following photodynamic therapy (PDT) for central serous chorioretinopathy (CSC). Methods. Case report. Results. By 1 month following PDT, mean (SD) choroidal thickness decreased from 562...

Cite
Wirostko WJ, Nordgren RN, Dubis AM. Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report. J Ophthalmol. 2012;2012:347206doi: 10.1155/2012/347206.
Wirostko, W. J., Nordgren, R. N., & Dubis, A. M. (2012). Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report. Journal of ophthalmology, 2012347206. https://doi.org/10.1155/2012/347206
Wirostko, William J, et al. "Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report." Journal of ophthalmology vol. 2012 (2012): 347206. doi: https://doi.org/10.1155/2012/347206
Wirostko WJ, Nordgren RN, Dubis AM. Topographical Choroidal Thickness Change Following PDT for CSC: An OCT Case Report. J Ophthalmol. 2012;2012:347206. doi: 10.1155/2012/347206. Epub 2012 Jan 12. PMID: 22292111; PMCID: PMC3265181.
Copy Download .nbib Format: NLM
Fully Convolutional Neural Networks Improve Abdominal Organ Segmentation.

Proceedings of SPIE--the International Society for Optical Engineering

Bobo MF, Bao S, Huo Y, Yao Y, Virostko J, Plassard AJ, Lyu I, Assad A, Abramson RG, Hilmes MA, Landman BA.
PMID: 29887665
Proc SPIE Int Soc Opt Eng. 2018 Mar;10574. doi: 10.1117/12.2293751.

Abdominal image segmentation is a challenging, yet important clinical problem. Variations in body size, position, and relative organ positions greatly complicate the segmentation process. Historically, multi-atlas methods have achieved leading results across imaging modalities and anatomical targets. However, deep...

Cite
Bobo MF, Bao S, Huo Y, et al. Fully Convolutional Neural Networks Improve Abdominal Organ Segmentation. Proc SPIE Int Soc Opt Eng. 2018;10574doi: 10.1117/12.2293751.
Bobo, M. F., Bao, S., Huo, Y., Yao, Y., Virostko, J., Plassard, A. J., Lyu, I., Assad, A., Abramson, R. G., Hilmes, M. A., & Landman, B. A. (2018). Fully Convolutional Neural Networks Improve Abdominal Organ Segmentation. Proceedings of SPIE--the International Society for Optical Engineering, 10574. https://doi.org/10.1117/12.2293751
Bobo, Meg F, et al. "Fully Convolutional Neural Networks Improve Abdominal Organ Segmentation." Proceedings of SPIE--the International Society for Optical Engineering vol. 10574 (2018). doi: https://doi.org/10.1117/12.2293751
Bobo MF, Bao S, Huo Y, Yao Y, Virostko J, Plassard AJ, Lyu I, Assad A, Abramson RG, Hilmes MA, Landman BA. Fully Convolutional Neural Networks Improve Abdominal Organ Segmentation. Proc SPIE Int Soc Opt Eng. 2018 Mar;10574. doi: 10.1117/12.2293751. PMID: 29887665; PMCID: PMC5992909.
Copy Download .nbib Format: NLM
Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting.

Journal of magnetic resonance imaging : JMRI

Sorace AG, Wu C, Barnes SL, Jarrett AM, Avery S, Patt D, Goodgame B, Luci JJ, Kang H, Abramson RG, Yankeelov TE, Virostko J.
PMID: 29570895
J Magn Reson Imaging. 2018 Mar 23; doi: 10.1002/jmri.26011. Epub 2018 Mar 23.

BACKGROUND: Quantitative diffusion-weighted MRI (DW-MRI) and dynamic contrast-enhanced MRI (DCE-MRI) have the potential to impact patient care by providing noninvasive biological information in breast cancer.PURPOSE/HYPOTHESIS: To quantify the repeatability, reproducibility, and accuracy of apparent diffusion coefficient (ADC) and TSTUDY...

Cite
Sorace AG, Wu C, Barnes SL, et al. Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting. J Magn Reson Imaging. 2018;doi: 10.1002/jmri.26011.
Sorace, A. G., Wu, C., Barnes, S. L., Jarrett, A. M., Avery, S., Patt, D., Goodgame, B., Luci, J. J., Kang, H., Abramson, R. G., Yankeelov, T. E., & Virostko, J. (2018). Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting. Journal of magnetic resonance imaging : JMRI, . https://doi.org/10.1002/jmri.26011
Sorace, Anna G, et al. "Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting." Journal of magnetic resonance imaging : JMRI vol. (2018). doi: https://doi.org/10.1002/jmri.26011
Sorace AG, Wu C, Barnes SL, Jarrett AM, Avery S, Patt D, Goodgame B, Luci JJ, Kang H, Abramson RG, Yankeelov TE, Virostko J. Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting. J Magn Reson Imaging. 2018 Mar 23; doi: 10.1002/jmri.26011. Epub 2018 Mar 23. PMID: 29570895; PMCID: PMC6151298.
Copy Download .nbib Format: NLM
Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities.

Journal of clinical medicine

Jarrett AM, Faghihi D, Ii DAH, Lima EABF, Virostko J, Biros G, Patt D, Yankeelov TE.
PMID: 32370195
J Clin Med. 2020 May 02;9(5). doi: 10.3390/jcm9051314.

Optimal control theory is branch of mathematics that aims to optimize a solution to a dynamical system. While the concept of using optimal control theory to improve treatment regimens in oncology is not novel, many of the early applications...

Cite
Jarrett AM, Faghihi D, Ii DAH, et al. Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities. J Clin Med. 2020;9(5)doi: 10.3390/jcm9051314.
Jarrett, A. M., Faghihi, D., Ii, D. A. H., Lima, E. A. B. F., Virostko, J., Biros, G., Patt, D., & Yankeelov, T. E. (2020). Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities. Journal of clinical medicine, 9(5), . https://doi.org/10.3390/jcm9051314
Jarrett, Angela M, et al. "Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities." Journal of clinical medicine vol. 9,5 (2020). doi: https://doi.org/10.3390/jcm9051314
Jarrett AM, Faghihi D, Ii DAH, Lima EABF, Virostko J, Biros G, Patt D, Yankeelov TE. Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities. J Clin Med. 2020 May 02;9(5). doi: 10.3390/jcm9051314. PMID: 32370195; PMCID: PMC7290915.
Copy Download .nbib Format: NLM
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area.

medRxiv : the preprint server for health sciences

Ng DL, Goldgof GM, Shy BR, Levine AG, Balcerek J, Bapat SP, Prostko J, Rodgers M, Coller K, Pearce S, Franz S, Du L, Stone M, Pillai SK, Sotomayor-Gonzalez A, Servellita V, Martin CSS, Granados A, Glasner DR, Han LM, Truong K, Akagi N, Nguyen DN, Neumann NM, Qazi D, Hsu E, Gu W, Santos YA, Custer B, Green V, Williamson P, Hills NK, Lu CM, Whitman JD, Stramer S, Wang C, Reyes K, Hakim JMC, Sujishi K, Alazzeh F, Pham L, Oon CY, Miller S, Kurtz T, Hackett J, Simmons G, Busch MP, Chiu CY.
PMID: 32511477
medRxiv. 2020 May 25; doi: 10.1101/2020.05.19.20107482.

We report very low SARS-CoV-2 seroprevalence in two San Francisco Bay Area populations. Seropositivity was 0.26% in 387 hospitalized patients admitted for non-respiratory indications and 0.1% in 1,000 blood donors. We additionally describe the longitudinal dynamics of immunoglobulin-G, immunoglobulin-M,...

Cite
Ng DL, Goldgof GM, Shy BR, et al. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area. medRxiv. 2020;doi: 10.1101/2020.05.19.20107482.
Ng, D. L., Goldgof, G. M., Shy, B. R., Levine, A. G., Balcerek, J., Bapat, S. P., Prostko, J., Rodgers, M., Coller, K., Pearce, S., Franz, S., Du, L., Stone, M., Pillai, S. K., Sotomayor-Gonzalez, A., Servellita, V., Martin, C. S. S., Granados, A., Glasner, D. R., Han, L. M., Truong, K., Akagi, N., Nguyen, D. N., Neumann, N. M., Qazi, D., Hsu, E., Gu, W., Santos, Y. A., Custer, B., Green, V., Williamson, P., Hills, N. K., Lu, C. M., Whitman, J. D., Stramer, S., Wang, C., Reyes, K., Hakim, J. M. C., Sujishi, K., Alazzeh, F., Pham, L., Oon, C. Y., Miller, S., Kurtz, T., Hackett, J., Simmons, G., Busch, M. P., & Chiu, C. Y. (2020). SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.05.19.20107482
Ng, Dianna L, et al. "SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.05.19.20107482
Ng DL, Goldgof GM, Shy BR, Levine AG, Balcerek J, Bapat SP, Prostko J, Rodgers M, Coller K, Pearce S, Franz S, Du L, Stone M, Pillai SK, Sotomayor-Gonzalez A, Servellita V, Martin CSS, Granados A, Glasner DR, Han LM, Truong K, Akagi N, Nguyen DN, Neumann NM, Qazi D, Hsu E, Gu W, Santos YA, Custer B, Green V, Williamson P, Hills NK, Lu CM, Whitman JD, Stramer S, Wang C, Reyes K, Hakim JMC, Sujishi K, Alazzeh F, Pham L, Oon CY, Miller S, Kurtz T, Hackett J, Simmons G, Busch MP, Chiu CY. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area. medRxiv. 2020 May 25; doi: 10.1101/2020.05.19.20107482. PMID: 32511477; PMCID: PMC7273245.
Copy Download .nbib Format: NLM
Longitudinal FRET Imaging of Glucose and Lactate Dynamics and Response to Therapy in Breast Cancer Cells.

Molecular imaging and biology

Yang J, Davis T, Kazerouni AS, Chen YI, Bloom MJ, Yeh HC, Yankeelov TE, Virostko J.
PMID: 34611767
Mol Imaging Biol. 2022 Feb;24(1):144-155. doi: 10.1007/s11307-021-01639-4. Epub 2021 Oct 05.

PURPOSE: The reprogramming of cellular metabolism is a hallmark of cancer. The ability to noninvasively assay glucose and lactate concentrations in cancer cells would improve our understanding of the dynamic changes in metabolic activity accompanying tumor initiation, progression, and...

Cite
Yang J, Davis T, Kazerouni AS, et al. Longitudinal FRET Imaging of Glucose and Lactate Dynamics and Response to Therapy in Breast Cancer Cells. Mol Imaging Biol. 2021;24(1):144-155doi: 10.1007/s11307-021-01639-4.
Yang, J., Davis, T., Kazerouni, A. S., Chen, Y. I., Bloom, M. J., Yeh, H. C., Yankeelov, T. E., & Virostko, J. (2022). Longitudinal FRET Imaging of Glucose and Lactate Dynamics and Response to Therapy in Breast Cancer Cells. Molecular imaging and biology, 24(1), 144-155. https://doi.org/10.1007/s11307-021-01639-4
Yang, Jianchen, et al. "Longitudinal FRET Imaging of Glucose and Lactate Dynamics and Response to Therapy in Breast Cancer Cells." Molecular imaging and biology vol. 24,1 (2022): 144-155. doi: https://doi.org/10.1007/s11307-021-01639-4
Yang J, Davis T, Kazerouni AS, Chen YI, Bloom MJ, Yeh HC, Yankeelov TE, Virostko J. Longitudinal FRET Imaging of Glucose and Lactate Dynamics and Response to Therapy in Breast Cancer Cells. Mol Imaging Biol. 2022 Feb;24(1):144-155. doi: 10.1007/s11307-021-01639-4. Epub 2021 Oct 05. PMID: 34611767.
Copy Download .nbib Format: NLM
Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice.

Frontiers in pharmacology

Dou S, Virostko J, Rusckowski M, Greiner DL, Powers AC, Liu G.
PMID: 25104938
Front Pharmacol. 2014 Jul 24;5:172. doi: 10.3389/fphar.2014.00172. eCollection 2014.

Although an increasing number of antibody conjugates are being used in the clinic, there remain many unmet needs in antibody targeting. Normal tissue background is one of the key issues that limits the therapeutic efficacy and the detection sensitivity....

Cite
Dou S, Virostko J, Rusckowski M, et al. Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice. Front Pharmacol. 2014;5:172doi: 10.3389/fphar.2014.00172.
Dou, S., Virostko, J., Rusckowski, M., Greiner, D. L., Powers, A. C., & Liu, G. (2014). Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice. Frontiers in pharmacology, 5172. https://doi.org/10.3389/fphar.2014.00172
Dou, Shuping, et al. "Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice." Frontiers in pharmacology vol. 5 (2014): 172. doi: https://doi.org/10.3389/fphar.2014.00172
Dou S, Virostko J, Rusckowski M, Greiner DL, Powers AC, Liu G. Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice. Front Pharmacol. 2014 Jul 24;5:172. doi: 10.3389/fphar.2014.00172. eCollection 2014. PMID: 25104938; PMCID: PMC4109569.
Copy Download .nbib Format: NLM
Patient preferences in the treatment of diabetic retinopathy.

Patient preference and adherence

Wirostko B, Beusterien K, Grinspan J, Ciulla T, Gonder J, Barsdorf A, Pleil A.
PMID: 21660105
Patient Prefer Adherence. 2011;5:229-37. doi: 10.2147/PPA.S11972. Epub 2011 May 24.

OBJECTIVE: Accounting for patient preferences may be especially important in diabetes mellitus, given the challenge in identifying factors associated with treatment adherence. Although preference studies have been performed in diabetes, none have examined treatments used in diabetic retinopathy (DR)....

Cite
Wirostko B, Beusterien K, Grinspan J, et al. Patient preferences in the treatment of diabetic retinopathy. Patient Prefer Adherence. 2011;5:229-37doi: 10.2147/PPA.S11972.
Wirostko, B., Beusterien, K., Grinspan, J., Ciulla, T., Gonder, J., Barsdorf, A., & Pleil, A. (2011). Patient preferences in the treatment of diabetic retinopathy. Patient preference and adherence, 5229-37. https://doi.org/10.2147/PPA.S11972
Wirostko, Barbara, et al. "Patient preferences in the treatment of diabetic retinopathy." Patient preference and adherence vol. 5 (2011): 229-37. doi: https://doi.org/10.2147/PPA.S11972
Wirostko B, Beusterien K, Grinspan J, Ciulla T, Gonder J, Barsdorf A, Pleil A. Patient preferences in the treatment of diabetic retinopathy. Patient Prefer Adherence. 2011;5:229-37. doi: 10.2147/PPA.S11972. Epub 2011 May 24. PMID: 21660105; PMCID: PMC3105876.
Copy Download .nbib Format: NLM
[Rare complication of surgery of an intervertebral disk (breaking of instrument).].

Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca

Lacko F, Zachar M, Výrostko J.
PMID: 20470523
Acta Chir Orthop Traumatol Cech. 1995;62(5):314-5.

The autors describe a rare complication which occured during surgery of an intervertebral disk -breaking of the surgical instrument. This complication is in some instance asymptomatic, in others it may cause major trouble to the patient. Key words: intervertebral...

Cite
Lacko F, Zachar M, Výrostko J. Zriedkavá komplikácia operácie mezistavcovej platnicky (zalomenie instrumentu). [Rare complication of surgery of an intervertebral disk (breaking of instrument).]. Acta Chir Orthop Traumatol Cech. 1995;62(5):314-5
Lacko, F., Zachar, M., & Výrostko, J. (1995). Zriedkavá komplikácia operácie mezistavcovej platnicky (zalomenie instrumentu). [Rare complication of surgery of an intervertebral disk (breaking of instrument).]. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca, 62(5), 314-5.
Lacko, F, et al. "Zriedkavá komplikácia operácie mezistavcovej platnicky (zalomenie instrumentu)." [Rare complication of surgery of an intervertebral disk (breaking of instrument).]. Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca vol. 62,5 (1995): 314-5.
Lacko F, Zachar M, Výrostko J. Zriedkavá komplikácia operácie mezistavcovej platnicky (zalomenie instrumentu). [Rare complication of surgery of an intervertebral disk (breaking of instrument).]. Acta Chir Orthop Traumatol Cech. 1995;62(5):314-5. Slovak. PMID: 20470523.
Copy Download .nbib Format: NLM
RetCam II Fluorescein Angiography to Guide Treatment and Diagnosis of Coats Disease.

Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye

Koozekanani DD, Connor TB, Wirostko WJ.
PMID: 20337287
Ophthalmic Surg Lasers Imaging. 2010 Mar 09;1-3. doi: 10.3928/15428877-20100215-86. Epub 2010 Mar 09.

Coats disease is a well-described clinical condition featuring peripheral leakage from telangiectatic vasculature, resulting in exudative retinal detachments and exudative deposits. It often affects pediatric patients, requiring examinations and treatments to be performed under anesthesia. It can be difficult...

Cite
Koozekanani DD, Connor TB, Wirostko WJ. RetCam II Fluorescein Angiography to Guide Treatment and Diagnosis of Coats Disease. Ophthalmic Surg Lasers Imaging. 2010;1-3doi: 10.3928/15428877-20100215-86.
Koozekanani, D. D., Connor, T. B., & Wirostko, W. J. (2010). RetCam II Fluorescein Angiography to Guide Treatment and Diagnosis of Coats Disease. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye, 1-3. https://doi.org/10.3928/15428877-20100215-86
Koozekanani, Dara D, et al. "RetCam II Fluorescein Angiography to Guide Treatment and Diagnosis of Coats Disease." Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye vol. (2010): 1-3. doi: https://doi.org/10.3928/15428877-20100215-86
Koozekanani DD, Connor TB, Wirostko WJ. RetCam II Fluorescein Angiography to Guide Treatment and Diagnosis of Coats Disease. Ophthalmic Surg Lasers Imaging. 2010 Mar 09;1-3. doi: 10.3928/15428877-20100215-86. Epub 2010 Mar 09. PMID: 20337287.
Copy Download .nbib Format: NLM
Ocular drug delivery for glaucoma management.

Pharmaceutics

Gooch N, Molokhia SA, Condie R, Burr RM, Archer B, Ambati BK, Wirostko B.
PMID: 24300188
Pharmaceutics. 2012 Mar 08;4(1):197-211. doi: 10.3390/pharmaceutics4010197.

Current glaucoma management modalities are hindered by low patient compliance and adherence. This can be due to highly complex treatment strategies or poor patient understanding. Treatments focus on the management or reduction of intraocular pressure. This is most commonly...

Cite
Gooch N, Molokhia SA, Condie R, et al. Ocular drug delivery for glaucoma management. Pharmaceutics. 2012;4(1):197-211doi: 10.3390/pharmaceutics4010197.
Gooch, N., Molokhia, S. A., Condie, R., Burr, R. M., Archer, B., Ambati, B. K., & Wirostko, B. (2012). Ocular drug delivery for glaucoma management. Pharmaceutics, 4(1), 197-211. https://doi.org/10.3390/pharmaceutics4010197
Gooch, Nathan, et al. "Ocular drug delivery for glaucoma management." Pharmaceutics vol. 4,1 (2012): 197-211. doi: https://doi.org/10.3390/pharmaceutics4010197
Gooch N, Molokhia SA, Condie R, Burr RM, Archer B, Ambati BK, Wirostko B. Ocular drug delivery for glaucoma management. Pharmaceutics. 2012 Mar 08;4(1):197-211. doi: 10.3390/pharmaceutics4010197. PMID: 24300188; PMCID: PMC3834906.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 37 entries